Liu Min, Zhu Zhijun, Sun Liying
Department of Liver Transplantation Center, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
National Clinical Research Centre for Digestive Diseases, Beijing Friendship Hospital, Capital Medical University, Beijing, China.
Front Med (Lausanne). 2021 Oct 4;8:687028. doi: 10.3389/fmed.2021.687028. eCollection 2021.
Invasive fungal infection (IFI) remains an important cause of mortality in liver transplantation (LT). The objective of this meta-analysis was to identify the risk factors for IFI after LT. We searched for relevant studies published up to June 2020 from PubMed, Web of Science, Embase, and the Cochrane Library. Odds ratios (ORs) and their corresponding 95% CIs were used to identify significant differences in the risk factors. Heterogeneity between studies was evaluated by the test, and potential publication bias was assessed with Egger's test. The quality of included studies was evaluated with the Newcastle-Ottawa Scale (NOS). A total of 14 studies enrolling 4,284 recipients were included in the meta-analysis. Reoperation (OR = 2.18, 95% CI: 1.61-2.94), posttransplantation dialysis (OR = 2.03, 95% CI: 1.52-2.72), bacterial infection (OR = 1.81, 95% CI: 1.33-2.46), live donor (OR = 1.78, 95% CI: 1.20-2.63), retransplantation (OR = 2.45, 95% CI: 1.54-3.89), and fungal colonization (OR = 2.60, 95% CI: 1.99-3.42) were associated with the risk factors of IFI after LT. Despite some risk factors that have been identified as significant factors for IFI post-LT, which may inform prevention recommendations, rigorous and well-designed studies with adequate sample sizes should be conducted to solve the limitations of this study.
侵袭性真菌感染(IFI)仍然是肝移植(LT)患者死亡的重要原因。本荟萃分析的目的是确定肝移植后IFI的危险因素。我们检索了截至2020年6月在PubMed、科学网、Embase和考科蓝图书馆发表的相关研究。采用优势比(OR)及其相应的95%置信区间(CI)来确定危险因素的显著差异。通过检验评估研究间的异质性,并用Egger检验评估潜在的发表偏倚。采用纽卡斯尔-渥太华量表(NOS)评估纳入研究的质量。本荟萃分析共纳入14项研究,涉及4284名受者。再次手术(OR = 2.18,95% CI:1.61 - 2.94)、移植后透析(OR = 2.03,95% CI:1.52 - 2.72)、细菌感染(OR = 1.81,95% CI:1.33 - 2.46)、活体供体(OR = 1.78,95% CI:1.20 - 2.63)、再次移植(OR = 2.45,95% CI:1.54 - 3.89)和真菌定植(OR = 2.60,95% CI:1.99 - 3.42)与肝移植后IFI的危险因素相关。尽管已确定一些危险因素是肝移植后IFI的重要因素,这可能为预防建议提供依据,但仍应开展样本量充足、严谨且设计良好的研究,以解决本研究的局限性。